Literature DB >> 22171274

Immune correlates of herpes zoster in HIV-infected children and youth.

Adriana Weinberg1, Sharon Huang, Lin-Ye Song, Terry Fenton, Paige Williams, Julie Patterson, Adriana Tovar-Salazar, Myron J Levin.   

Abstract

To identify immunologic factors that modulate the risk of herpes zoster (HZ), we compared varicella-zoster virus (VZV)-specific and nonspecific T-cell subpopulations of 47 HIV-infected children before they developed HZ with those of 141 VZV-positive HZ-negative matched controls. Compared with controls, HZ cases had lower VZV-specific CD8(+) CD107a(+) cell percentages independently of CD4(+) percentages or HIV loads, suggesting that VZV-specific cytotoxic T cells are protective against HZ. In contrast, high nonspecific regulatory and activated T cells were associated with an increased risk of HZ.

Entities:  

Mesh:

Year:  2011        PMID: 22171274      PMCID: PMC3302278          DOI: 10.1128/JVI.06623-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Detection of T-cell degranulation: CD107a and b.

Authors:  Michael R Betts; Richard A Koup
Journal:  Methods Cell Biol       Date:  2004       Impact factor: 1.441

2.  De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells.

Authors:  Mindi R Walker; Bryan D Carson; Gerald T Nepom; Steven F Ziegler; Jane H Buckner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

Review 3.  A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.

Authors:  Jason D Fontenot; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

Review 4.  License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC.

Authors:  George Vlad; Raffaello Cortesini; Nicole Suciu-Foca
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

5.  CD27/CFSE-based ex vivo selection of highly suppressive alloantigen-specific human regulatory T cells.

Authors:  Hans J P M Koenen; Esther Fasse; Irma Joosten
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

6.  A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  M N Oxman; M J Levin; G R Johnson; K E Schmader; S E Straus; L D Gelb; R D Arbeit; M S Simberkoff; A A Gershon; L E Davis; A Weinberg; K D Boardman; H M Williams; J Hongyuan Zhang; P N Peduzzi; C E Beisel; V A Morrison; J C Guatelli; P A Brooks; C A Kauffman; C T Pachucki; K M Neuzil; R F Betts; P F Wright; M R Griffin; P Brunell; N E Soto; A R Marques; S K Keay; R P Goodman; D J Cotton; J W Gnann; J Loutit; M Holodniy; W A Keitel; G E Crawford; S-S Yeh; Z Lobo; J F Toney; R N Greenberg; P M Keller; R Harbecke; A R Hayward; M R Irwin; T C Kyriakides; C Y Chan; I S F Chan; W W B Wang; P W Annunziato; J L Silber
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

7.  The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients.

Authors:  Jan Andersson; Adriano Boasso; Jakob Nilsson; Rui Zhang; Norah J Shire; Stefan Lindback; Gene M Shearer; Claire A Chougnet
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

8.  Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo.

Authors:  Sigrid E Sandner; Michael R Clarkson; Alan D Salama; Alberto Sanchez-Fueyo; Christoph Domenig; Antje Habicht; Nader Najafian; Hideo Yagita; Miyuki Azuma; Laurence A Turka; Mohamed H Sayegh
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

9.  Herpes zoster, immunological deterioration and disease progression in HIV-1 infection.

Authors:  J Veenstra; A Krol; R M van Praag; P H Frissen; P T Schellekens; J M Lange; R A Coutinho; J T van der Meer
Journal:  AIDS       Date:  1995-10       Impact factor: 4.177

10.  Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells.

Authors:  Megan K Levings; Silvia Gregori; Eleonora Tresoldi; Sabrina Cazzaniga; Chiara Bonini; Maria Grazia Roncarolo
Journal:  Blood       Date:  2004-10-12       Impact factor: 22.113

View more
  11 in total

1.  Immune Correlates of Herpes Zoster in People Living with HIV on Effective Antiretroviral Therapy.

Authors:  Adriana Tovar Salazar; Ashley McKhann; Huichao Chen; Ronald J Bosch; Adriana Weinberg
Journal:  AIDS Res Hum Retroviruses       Date:  2019-07-16       Impact factor: 2.205

2.  High Constitutive Interleukin 10 Level Interferes With the Immune Response to Varicella-Zoster Virus in Elderly Recipients of Live Attenuated Zoster Vaccine.

Authors:  Anne A Gershon; David Brooks; Donald D Stevenson; William K Chin; Michael B A Oldstone; Michael D Gershon
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

3.  Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.

Authors:  Adriana Weinberg; Jennifer Canniff; Nadine Rouphael; Aneesh Mehta; Mark Mulligan; Jennifer A Whitaker; Myron J Levin
Journal:  J Immunol       Date:  2017-06-12       Impact factor: 5.422

4.  The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.

Authors:  Adriana Weinberg; Lei Pang; Michael J Johnson; Yupanqui Caldas; Alice Cho; Adriana Tovar-Salazar; Jennifer Canniff; Kenneth E Schmader; Zoran Popmihajlov; Myron J Levin
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

Review 5.  Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?

Authors:  Anne A Gershon
Journal:  J Infect       Date:  2017-06       Impact factor: 6.072

6.  Immunological characteristics of MAV/06 strain of varicella-zoster virus vaccine in an animal model.

Authors:  Duckhyang Shin; Younchul Shin; Eunmi Kim; Hyojung Nam; Haiyan Nan; Jaewoo Lee
Journal:  BMC Immunol       Date:  2022-06-03       Impact factor: 3.594

7.  Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians.

Authors:  Benson Ogunjimi; Evelien Smits; Steven Heynderickx; Johan Van den Bergh; Joke Bilcke; Hilde Jansens; Ronald Malfait; Jose Ramet; Holden T Maecker; Nathalie Cools; Philippe Beutels; Pierre Van Damme
Journal:  Clin Vaccine Immunol       Date:  2014-01-15

8.  B and T Cell Phenotypic Profiles of African HIV-Infected and HIV-Exposed Uninfected Infants: Associations with Antibody Responses to the Pentavalent Rotavirus Vaccine.

Authors:  Adriana Weinberg; Jane Lindsey; Ronald Bosch; Deborah Persaud; Paul Sato; Anthony Ogwu; Aida Asmelash; Mutsa Bwakura-Dangarambezi; Benjamin H Chi; Jennifer Canniff; Shahin Lockman; Simani Gaseitsiwe; Sikhulile Moyo; Christiana Elizabeth Smith; Natasha O Moraka; Myron J Levin
Journal:  Front Immunol       Date:  2018-01-19       Impact factor: 7.561

9.  Herpes Zoster in Persons Living with HIV-1 Infection: Viremia and Immunological Defects Are Strong Risk Factors in the Era of Combination Antiretroviral Therapy.

Authors:  Nathaniel B Erdmann; Heather A Prentice; Anju Bansal; Howard W Wiener; Greer Burkholder; Sadeep Shrestha; Jianming Tang
Journal:  Front Public Health       Date:  2018-03-12

10.  A Study of the Changes of T Helper 17 Cells and Regulatory T Cells in Herpes Zoster.

Authors:  Min Sung Kim; Dong Jin Kim; Chan Ho Na; Bong Seok Shin
Journal:  Ann Dermatol       Date:  2017-08-25       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.